News & Events
- August 1, 2012
-
July 26, 2012
Approval of new drugs slowing
Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, adding to the many stresses on the pharmaceutical industry. The Food and Drug Administration approved only 14 innovative drugs in the first half of this year, down from 18 in the first half... -
July 13, 2012 - July 19, 2012
CAMD Participates in International Alzheimer’s Conference
The Alzheimer’s Association International Conference was held July 13-19, 2012 in Vancouver, BC and brought together 4,300 researchers and scientists. The conference is the largest global meeting of its kind and draws researchers from around the world to report on and to discuss groundbreaking research and information on the causes, diagnosis, treatments, and prevention of... -
July 10, 2012
Tucson tech: Tucson’s C-Path drug institute looks to boost its future funding
Tucson’s Critical Path Institute recently got some good news – and some noteworthy recognition – when the U.S. Senate gave final approval to a budget reauthorization bill including the Food and Drug Administration partnership program that helps fund the institute. -
June 21, 2012
CDISC, C-Path and FDA Collaborate to Develop Data Standards to Streamline Path to New Therapies
The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the signing of a partnership sagreement to establish the Coalition For Accelerating Standards and Therapies, or CFAST, an initiative to accelerate clinical research and medical product development by creating and maintaining data standards, tools and methods for conducting research in therapeutic...